Spatial localization of the Ebola virus glycoprotein mucin-like domain determined by cryo-electron tomography

Erin E H Tran1, James A Simmons2, Alberto Bartesaghi1

  • 1Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

Journal of Virology
|July 11, 2014
PubMed

Insights

The Ebola virus glycoprotein mucin-like domain (MLD) is crucial for viral entry and immune evasion. This study reveals the MLD

Area of Science:

  • Virology
  • Structural Biology
  • Immunology

Background:

  • The Ebola virus glycoprotein (GP) mediates viral entry into host cells.
  • The mucin-like domain (MLD) of the GP is known to be involved in cell entry and immune evasion.
  • Understanding the structural role of the MLD is critical for developing antiviral strategies.

Purpose of the Study:

  • To determine the three-dimensional structure of the full-length Ebola virus glycoprotein in a near-native state.
  • To elucidate the structural location and implications of the mucin-like domain (MLD).

Main Methods:

  • Cryo-electron tomography was used to visualize Ebola virus-like particles.
  • Three-dimensional reconstruction of the full-length glycoprotein was performed.
  • Structural comparison between the full-length glycoprotein and a glycoprotein lacking the MLD.

Main Results:

  • A near-native, three-dimensional structure of the full-length Ebola virus glycoprotein was determined.
  • The MLD was localized to the apex and sides of each glycoprotein monomer.
  • Significant structural differences were observed when comparing the full-length glycoprotein to the MLD-lacking variant.

Conclusions:

  • The determined structure provides a template for understanding MLD function in Ebola virus.
  • The structural insights into MLD localization may inform the development of novel therapeutics targeting viral entry.
  • This work enhances our understanding of Ebola virus pathogenesis and immune evasion mechanisms.